152 related articles for article (PubMed ID: 11830874)
1. [Toxoplasma encephalitis in a previously healthy man].
Kupila L; Sonninen V; Peltonen R; Uksila J; Hukkanen V; Kotilainen P
Duodecim; 1999; 115(3):284-8. PubMed ID: 11830874
[No Abstract] [Full Text] [Related]
2. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
3. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
Van Delden C; Hirschel B
J Infect Dis; 1996 May; 173(5):1294-5. PubMed ID: 8627092
[No Abstract] [Full Text] [Related]
4. Issues in toxoplasmosis.
McCabe R; Chirurgi V
Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
[TBL] [Abstract][Full Text] [Related]
5. A healthy, 81-year-old woman with toxoplasmic encephalitis.
Kanno A; Suzuki Y; Minami M; Ogawa K; Oishi M; Kamei S
Geriatr Gerontol Int; 2012 Oct; 12(4):759-61. PubMed ID: 22998383
[No Abstract] [Full Text] [Related]
6. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Araujo FG; Suzuki Y; Remington JS
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
[TBL] [Abstract][Full Text] [Related]
7. Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Iribarren JA; Arrizabalaga J; Garde C; Rodriguez-Arrondo F; Blanco A
Arch Intern Med; 1992 Oct; 152(10):2139-40. PubMed ID: 1417389
[No Abstract] [Full Text] [Related]
8. [Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis].
Fernández-Ayala M; Fariñas MC; Nan D; González-Macías J
An Med Interna; 2000 Nov; 17(11):616-7. PubMed ID: 11322040
[No Abstract] [Full Text] [Related]
9. Toxoplasmosis in AIDS: keeping the lid on.
Kovacs JA
Ann Intern Med; 1995 Aug; 123(3):230-1. PubMed ID: 7598306
[No Abstract] [Full Text] [Related]
10. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
[TBL] [Abstract][Full Text] [Related]
11. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
[No Abstract] [Full Text] [Related]
13. A solitary brain lesion in a patient with AIDS.
Ball SC
AIDS Read; 2003 Jan; 13(1):11-4. PubMed ID: 12569890
[No Abstract] [Full Text] [Related]
14. [Renal failure caused by sulfadiazine in a HIV patient with toxoplasmic encephalitis].
Solano Remírez M; Oliván Ballabriga AS; da Costa Rodríguez GM; Alvarez Frías MT; González Arencibia C
An Med Interna; 2005 Aug; 22(8):395-6. PubMed ID: 16351495
[No Abstract] [Full Text] [Related]
15. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
16. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
17. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral toxoplasmosis complicating an allograft with hematopoietic stem cells from peripheral blood].
Dugauquier C; Bataille Y; Willems E; Frère P; De Prijck B; Beguin Y; Baron F
Rev Med Liege; 2009; 64(7-8):366-9. PubMed ID: 19777912
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases.
Hein R; Brunkhorst R; Thon WF; Schedel I; Schmidt RE
Clin Nephrol; 1993 May; 39(5):254-6. PubMed ID: 8513601
[TBL] [Abstract][Full Text] [Related]
20. [Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
Olmos Soto S; Reus Bañuls S; Mora Castera E; Villarubia Lor MB
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):549-50. PubMed ID: 24913993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
